Adoption of Artificial Intelligence in Biopharmaceutics
Priyanka Aswal, Piyush Verma, Gunjan Shaily and Ridhi
Published: January 04, 2022
The use of AI has transformed the approaches of a pathway or target identification to treat ailments. This was conceivable owing to the incorporation of genomics information, biochemical attributes, and target tractability. The use of AI has significantly caused pharma companies with increasing productivity, reproducibility, and repeatability of manufacturing as well as clinical trial processes. AI has considerably reduced the cost and time required to achieve the target required.